FDA Inspection
Weleda AGWeleda AG – FDA Inspection, Jun 15, 2018
Record Details
This FDA Inspection record concerns Weleda AG, with an inspection on June 15, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Christopher R. Czajka (FDA Associated Person)
- Vioela Respress (Issuing Officer)
View Company Profile
ID · 4af970c0-a255-4c1a-a7c5-25620c393201
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1061389
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Weleda AG
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 17, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 21, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 10, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 12, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 13, 2012 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
Other documents for Weleda AG
- FDA Inspection 1290150 - 2024-07-17
- FDA Inspection 1154630 - 2019-11-21
- FDA Inspection 978925 - 2016-06-10
- FDA Inspection 794146 - 2012-04-12
- FDA Inspection 776626 - 2012-03-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.